Abstract
Cardiac transplantation is one treatment option for patients with end stage cardiac amyloidosis. Selection criteria are not accurately defined and published outcomes do not resemble those of the general transplant population. Recurrence of amyloid deposition in the heart after transplant has been reported. We report our experience with heart transplants in AL amyloidosis patients with subsequent bone marrow transplant (BMT) and 1year outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
